CymaBay Therapeutics, Inc.·4

Jan 6, 7:33 PM ET

CymaBay Therapeutics, Inc. 4

4 · CymaBay Therapeutics, Inc. · Filed Jan 6, 2017

Insider Transaction Report

Form 4
Period: 2017-01-04
OMara Patrick J.
VP, Business Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2017-01-04+12,50025,000 total
    Exercise: $1.82From: 2017-01-04Exp: 2026-07-24Common Stock (12,500 underlying)
Footnotes (1)
  • [F1]On July 25, 2016, the Reporting Person was granted an option to purchase 25,000 shares of common stock of the Issuer. The option vests in two equal installments based on the Issuer's achieving certain milestones. The first milestone was met on December 30, 2016, resulting in vesting of the option as to 12,500 shares, which was reported on a prior Form 4. The second milestone was met on January 4, 2017, resulting in vesting of the option as to the remaining 12,500 shares.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -